Lv1
50 积分 2023-09-04 加入
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
8天前
已完结
pancreatic cancer
9天前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
20天前
已完结
First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer
24天前
已完结
Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations
1个月前
已完结
Potent Covalent Irreversible Inhibitor of KRAS G12C IBI351 in Patients with Advanced Solid Tumors: First-In-Human Phase I Study
2个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
2个月前
已完结
Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report
2个月前
已完结
A single-arm, phase II study of sotorasib plus carboplatin/pemetrexed in advanced non-squamous non-small cell lung cancer patients with KRAS G12C mutation (WJOG14821L, SCARLET)
2个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
3个月前
已完结
皖公网安备34019202002308
